[시장보고서]세계의 톡소플라즈마증 검사 시장 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2033년)

세계의 톡소플라즈마증 검사 시장 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2033년)

Toxoplasmosis Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

상품코드 : 1500809

리서치사 : Persistence Market Research

발행일 : 2024년 06월

페이지 정보 : 영문 238 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,009,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,237,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 11,921,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Persistence Market Research는 전 세계 톡소플라즈마증 검사 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회 및 과제를 포함한 중요한 시장 역학을 철저히 평가하고 시장 구조에 대한 자세한 통찰력을 제공합니다.

주요 인사이트

톡소플라즈마증 검사 시장 규모(2024E) : 22억 달러
예측 시장 규모(2033F) : 35억 달러
세계 시장 성장률(CAGR 2024-2033년) : 5.3%

톡소플라즈마증 검사 시장 : 조사 범위

톡소플라즈마증 검사는 기생충 톡소플라즈마 곤디에 의한 감염증의 진단과 관리에 중요한 역할을 하고 있습니다. 이러한 검사에는 다양한 임상 표본에서 항체 및 기생충 자체의 존재를 검출하기 위한 혈청학적 분석, 분자진단 및 영상 진단 기술이 포함됩니다. 이 시장은 병원, 진료소, 진단 실험실, 연구 기관을 대상으로 하고 있으며, PCR, ELISA, 영상 진단 등 다양한 검사법을 제공합니다.

시장 성장 촉진요인:

세계의 톡소플라즈마증 검사 시장은 톡소플라즈마증이 특히 임신한 여성과 면역결핍 환자에게 심각한 건강 우려사항이라는 인식 증가와 같은 몇 가지 중요한 요인들에 의해 견인되고 있습니다. 식습관의 변화나 반려동물의 사육 동향 등의 요인에 의해 톡소플라즈마증 감염의 이환율이 상승하고 있는 것이, 시장의 확대를 더욱 뒷받침하고 있습니다. 신속한 분자 분석 및 자동화 플랫폼 개발과 같은 진단 기술의 기술적 진보는 진단 정확도와 워크플로우의 효율성을 높이고 시장 성장을 가속하고 있습니다. 또한 건강 관리 지출을 확대하고 전염병 관리 개선을 목적으로 한 정부의 지원책이 시장 개척에 기여하고 있습니다.

시장 성장 억제요인:

유망한 성장이 예상되는 것, 톡소플라즈마증 검사 시장은 특히 신흥국 지역의 농촌 지역이나 충분한 서비스를 받지 못한 지역에서의 검사 시설에의 접근에 관한 과제에 직면하고 있습니다. 또한 규제상의 장애물과 톡소플라즈마증 검사법에 대한 상환 정책의 차이도 시장 침투의 제약 요인이 되고 있습니다. 또한 진단 검사의 정확성에 대한 우려와 종종 톡소플라즈마 감염의 무증상성은 검사율과 시장 성장 가능성에 영향을 미치고 있습니다.

시장 기회:

톡소플라즈마증 검사 시장은 진단 플랫폼의 기술 혁신, 건강 관리 계발 캠페인 증가, 포인트 오브 케어 검사 솔루션의 통합에 의해 큰 성장 기회를 가져옵니다. 또한 원격 의료 및 원격 진단 서비스의 채택은 특히 지리적으로 분산된 사람들에게 시장 도달범위를 확대합니다. 또한 진단 회사, 의료 서비스 제공업체, 공중 보건 기관이 전략적으로 협력하고 검사의 용이성과 구매 용이성을 향상시키는 것은 시장 확대에 매우 중요합니다.

이 보고서에서 다루는 주요 질문

세계의 톡소플라즈마증 검사 시장의 성장을 가속하는 주요 요인은?
다른 건강 관리 환경에서 어떤 진단 방법과 기술이 톡소플라즈마증 검사의 채택을 선도하고 있는가?
기술의 진보는 톡소플라즈마증 검사 시장 경쟁 구도를 어떻게 바꾸고 있는가?
톡소플라즈마증 검사 시장에 기여하고 있는 주요 기업은 누구이며, 시장의 관련성을 유지하기 위해 어떤 전략을 채용하고 있는가?
세계의 톡소플라즈마증 검사 시장에서의 새로운 동향과 미래성은?

소개/ 주요 조사 결과
2019-2023년에 있어서의 검사 유형별 시장 규모의 역사적 분석
현재 및 미래 시장 규모 분석과 예측, 검사 유형별(2024-2033년)
- 혈청학적 검사
  - 염료 테스트
  - 간접적혈구응집반응 검정
  - 직접 응집 분석
- ELISA
- PCR
- 초음파
- MRI
- 생검
검사 유형별 시장의 매력 분석

제8장 샘플별 세계 시장 분석

소개/ 주요 조사 결과
과거 시장 규모 분석, 샘플별(2019-2023년)
현재 및 미래 시장 규모의 분석과 예측(샘플별(2024-2033년))
- 혈액 샘플
- 양수
- 뇌척수액
샘플에 의한 시장의 매력 분석

제9장 최종 사용자별 세계 시장 분석

소개/ 주요 조사 결과
과거 시장 규모 분석, 최종 사용자별(2019-2023년)
현재 및 미래 시장 규모의 분석과 예측, 최종 사용자별(2024-2033년)
- 병원
- 클리닉
- 진단 실험실
최종 사용자별 시장의 매력 분석

제10장 지역별 세계 시장 분석

소개
2019-2023년에 있어서의 지역별 시장 규모의 역사적 분석
현재 및 미래 시장 규모의 지역별 분석과 예측(2024-2033년)
- 북미
- 라틴아메리카
- 유럽
- 남아시아
- 동아시아
- 오세아니아
- 중동 및 아프리카
지역별 시장의 매력 분석

제11장 북미 시장 분석

제12장 라틴아메리카 시장 분석

제13장 유럽 시장 분석

제14장 동아시아 시장 분석

제15장 남아시아 시장 분석

제16장 오세아니아 시장 분석

제17장 중동 및 아프리카 시장 분석

제18장 시장 구조 분석

기업계층별 시장 분석(마터니티케어 제품)
주요 기업의 시장 점유율 분석
시장 집중

제19장 경쟁 분석

경쟁 대시보드
주요 기업에 의한 브랜딩 및 프로모션 전략
주요 개발 분석
경쟁의 상세
- Abbott Laboratories
- Bio-Rad Laboratories Inc
- Affymetrix Inc.
- Beckman Coulter Inc.
- Biotest
- Cepheid Inc.
- GenBio
- Danaher Corporation
- Thermo Fisher Scientific
- Biomerica Inc.
- Biomerix

제20장 사용된 전제조건과 약어

제21장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for toxoplasmosis testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Toxoplasmosis Testing Market Size (2024E): USD 2.2 Billion
Projected Market Value (2033F): USD 3.5 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

Toxoplasmosis Testing Market - Report Scope:

Toxoplasmosis testing plays a crucial role in diagnosing and managing infections caused by the parasite Toxoplasma gondii. These tests include serological assays, molecular diagnostics, and imaging techniques aimed at detecting antibodies or the presence of the parasite itself in various clinical specimens. The market caters to hospitals, clinics, diagnostic laboratories, and research institutions, offering a range of testing methods such as PCR, ELISA, and imaging modalities.

Market Growth Drivers:

The global toxoplasmosis testing market is driven by several key factors, including increasing awareness about toxoplasmosis as a significant health concern, particularly for pregnant women and immunocompromised individuals. The rising incidence of toxoplasmosis infections, fueled by factors such as changing dietary habits and pet ownership trends, further propels market expansion. Technological advancements in diagnostic techniques, such as the development of rapid molecular assays and automated platforms, enhance diagnostic accuracy and workflow efficiency, driving market growth. Moreover, expanding healthcare expenditure and supportive government initiatives aimed at improving infectious disease management contribute to market development.

Market Restraints:

Despite promising growth prospects, the toxoplasmosis testing market faces challenges related to accessibility to testing facilities in rural and underserved areas, particularly in developing regions. Regulatory hurdles and varying reimbursement policies for toxoplasmosis testing procedures also pose constraints on market penetration. Additionally, concerns regarding the accuracy of diagnostic tests and the asymptomatic nature of toxoplasmosis infections in many cases impact testing rates and market growth potential.

Market Opportunities:

The toxoplasmosis testing market presents significant growth opportunities driven by technological innovations in diagnostic platforms, increasing healthcare awareness campaigns, and the integration of point-of-care testing solutions. The adoption of telemedicine and remote diagnostic services also broadens market reach, particularly in geographically dispersed populations. Furthermore, strategic collaborations between diagnostic companies, healthcare providers, and public health agencies to improve testing accessibility and affordability are crucial for market expansion.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the toxoplasmosis testing market globally?
Which diagnostic methods and technologies are leading the toxoplasmosis testing adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the toxoplasmosis testing market?
Who are the key players contributing to the toxoplasmosis testing market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global toxoplasmosis testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global toxoplasmosis testing market, including Roche Diagnostics, Thermo Fisher Scientific, and Bio-Rad Laboratories, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic assays, expand their geographical presence, and enhance market penetration. Collaboration with healthcare providers, academic institutions, and regulatory bodies facilitates product approvals and market access, driving technological innovation and market growth.

Key Companies Profiled:

Abbott Laboratories
Bio-Rad Laboratories Inc
Affymetrix Inc.
Beckman Coulter Inc.
Biotest
Cepheid Inc.
GenBio
Danaher Corporation
Thermo Fisher Scientific
Biomerica Inc.
Biomerix

Key Segments of Toxoplasmosis Testing Industry Research

Test Type:

Serological Tests
ELISA
PCR
Ultrasound
MRI
Biopsy

Sample:

Blood Samples
Amniotic Fluid
Cerebrospinal Fluid

End User:

Hospitals
Clinics
Diagnostic Laboratories

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions/Exclusions

3. Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Value Added Insights

4.1. Product Adoption Analysis
4.2. Product Usage Analysis
4.3. Regulatory Framework
4.4. Recent Product Approvals/Launches
4.5. Porter's Analysis
4.6. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global Per Capita Healthcare Spending
- 5.1.2. Global Life Expectancy Outlook
- 5.1.3. Global Research and Development Funding Outlook
- 5.1.4. Global Infectious Disease Testing Market (Parent Market Analysis)
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increasing prevalence of toxoplasmosis
- 5.2.2. Evolving healthcare policies and clinical guidelines
- 5.2.3. Advancements in Diagnostic Technologies
- 5.2.4. Research and Development
- 5.2.5. Public Health Campaigns
- 5.2.6. Pregnancy Care Emphasis
- 5.2.7. Regulatory Approvals
- 5.2.8. Patient Awareness and Education
- 5.2.9. Emerging Healthcare Markets
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. Global Market Demand (in Value or Size in US$ Million) Analysis 2019-2023 and Forecast, 2024-2033

6.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
6.2. Historical Market Value (US$ Million) Analysis, 2019-2023
6.3. Current and Future Market Value (US$ Million) Projections, 2024-2033
- 6.3.1. Y-o-Y Growth Trend Analysis
- 6.3.2. Absolute $ Opportunity Analysis

7. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Test Type

7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Test Type, 2019-2023
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2024-2033
- 7.3.1. Serological Test
  - 7.3.1.1. Dye Test
  - 7.3.1.2. Indirect Hemagglutination Assay
  - 7.3.1.3. Direct agglutination Assay
- 7.3.2. ELISA
- 7.3.3. PCR
- 7.3.4. Ultrasound
- 7.3.5. MRI
- 7.3.6. Biopsy
7.4. Market Attractiveness Analysis By Test Type

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Sample

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis, By Sample, 2019-2023
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample, 2024-2033
- 8.3.1. Blood Sample
- 8.3.2. Amniotic Fluid
- 8.3.3. Cerebrospinal Fluid
8.4. Market Attractiveness Analysis By Sample

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis, By End User, 2019-2023
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2024-2033
- 9.3.1. Hospitals
- 9.3.2. Clinics
- 9.3.3. Diagnostic Laboratories
9.4. Market Attractiveness Analysis By End User

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis, By Region, 2019-2023
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2024-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. South Asia
- 10.3.5. East Asia
- 10.3.6. Oceania
- 10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

11.1. Introduction
11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
- 11.3.1. By Country
  - 11.3.1.1. United States
  - 11.3.1.2. Canada
- 11.3.2. By Test Type
- 11.3.3. By Sample
- 11.3.4. By End User
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Test Type
- 11.4.3. By Sample
- 11.4.4. By End User
11.5. Market Trends
11.6. Market Drivers & Restraints - Impact Analysis
11.7. Country Level Analysis & Forecast
- 11.7.1. United States Market
  - 11.7.1.1. Introduction
  - 11.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 11.7.1.2.1. By Test Type
    - 11.7.1.2.2. By Sample
    - 11.7.1.2.3. By End User
- 11.7.2. Canada Market
  - 11.7.2.1. Introduction
  - 11.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 11.7.2.2.1. By Test Type
    - 11.7.2.2.2. By Sample
    - 11.7.2.2.3. By End User

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. Brazil
  - 12.3.1.2. Mexico
  - 12.3.1.3. Argentina
  - 12.3.1.4. Rest of LATAM
- 12.3.2. By Test Type
- 12.3.3. By Sample
- 12.3.4. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Test Type
- 12.4.3. By Sample
- 12.4.4. By End User
12.5. Market Trends
12.6. Market Drivers & Restraints - Impact Analysis
12.7. Country Level Analysis & Forecast
- 12.7.1. Brazil Market
  - 12.7.1.1. Introduction
  - 12.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.7.1.2.1. By Test Type
    - 12.7.1.2.2. By Sample
    - 12.7.1.2.3. By End User
- 12.7.2. Mexico Market
  - 12.7.2.1. Introduction
  - 12.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.7.2.2.1. By Test Type
    - 12.7.2.2.2. By Sample
    - 12.7.2.2.3. By End User
- 12.7.3. Argentina Market
  - 12.7.3.1. Introduction
  - 12.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 12.7.3.2.1. By Test Type
    - 12.7.3.2.2. By Sample
    - 12.7.3.2.3. By End User

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. United Kingdom
  - 13.3.1.2. Germany
  - 13.3.1.3. France
  - 13.3.1.4. Italy
  - 13.3.1.5. Spain
  - 13.3.1.6. BENELUX
  - 13.3.1.7. Russia
  - 13.3.1.8. Rest of Europe
- 13.3.2. By Test Type
- 13.3.3. By Sample
- 13.3.4. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Test Type
- 13.4.3. By Sample
- 13.4.4. By End User
13.5. Market Trends
13.6. Market Drivers & Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
- 13.7.1. United Kingdom Market
  - 13.7.1.1. Introduction
  - 13.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.7.1.2.1. By Test Type
    - 13.7.1.2.2. By Sample
    - 13.7.1.2.3. By End User
- 13.7.2. Germany Market
  - 13.7.2.1. Introduction
  - 13.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.7.2.2.1. By Test Type
    - 13.7.2.2.2. By Sample
    - 13.7.2.2.3. By End User
- 13.7.3. France Market
  - 13.7.3.1. Introduction
  - 13.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.7.3.2.1. By Test Type
    - 13.7.3.2.2. By Sample
    - 13.7.3.2.3. By End User
- 13.7.4. Italy Market
  - 13.7.4.1. Introduction
  - 13.7.4.2. Market Analysis and Forecast by Market Taxonomy
    - 13.7.4.2.1. By Test Type
    - 13.7.4.2.2. By Sample
    - 13.7.4.2.3. By End User
- 13.7.5. Spain Market
  - 13.7.5.1. Introduction
  - 13.7.5.2. Market Analysis and Forecast by Market Taxonomy
    - 13.7.5.2.1. By Test Type
    - 13.7.5.2.2. By Sample
    - 13.7.5.2.3. By End User
- 13.7.6. BENELUX Market
  - 13.7.6.1. Introduction
  - 13.7.6.2. Market Analysis and Forecast by Market Taxonomy
    - 13.7.6.2.1. By Test Type
    - 13.7.6.2.2. By Sample
    - 13.7.6.2.3. By End User
- 13.7.7. Russia Market
  - 13.7.7.1. Introduction
  - 13.7.7.2. Market Analysis and Forecast by Market Taxonomy
    - 13.7.7.2.1. By Test Type
    - 13.7.7.2.2. By Sample
    - 13.7.7.2.3. By End User

14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. China
  - 14.3.1.2. Japan
  - 14.3.1.3. South Korea
- 14.3.2. By Test Type
- 14.3.3. By Sample
- 14.3.4. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Test Type
- 14.4.3. By Sample
- 14.4.4. By End User
14.5. Market Trends
14.6. Market Drivers & Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
- 14.7.1. China Market
  - 14.7.1.1. Introduction
  - 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.7.1.2.1. By Test Type
    - 14.7.1.2.2. By Sample
    - 14.7.1.2.3. By End User
- 14.7.2. Japan Market
  - 14.7.2.1. Introduction
  - 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.7.2.2.1. By Test Type
    - 14.7.2.2.2. By Sample
    - 14.7.2.2.3. By End User
- 14.7.3. South Korea Market
  - 14.7.3.1. Introduction
  - 14.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.7.3.2.1. By Test Type
    - 14.7.3.2.2. By Sample
    - 14.7.3.2.3. By End User

15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. India
  - 15.3.1.2. Indonesia
  - 15.3.1.3. Thailand
  - 15.3.1.4. Malaysia
  - 15.3.1.5. Rest of South Asia
- 15.3.2. By Test Type
- 15.3.3. By Sample
- 15.3.4. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Test Type
- 15.4.3. By Sample
- 15.4.4. By End User
15.5. Market Trends
15.6. Market Drivers & Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
- 15.7.1. India Market
  - 15.7.1.1. Introduction
  - 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.7.1.2.1. By Test Type
    - 15.7.1.2.2. By Sample
    - 15.7.1.2.3. By End User
- 15.7.2. Indonesia Market
  - 15.7.2.1. Introduction
  - 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.7.2.2.1. By Test Type
    - 15.7.2.2.2. By Sample
    - 15.7.2.2.3. By End User
- 15.7.3. Thailand Market
  - 15.7.3.1. Introduction
  - 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.7.3.2.1. By Test Type
    - 15.7.3.2.2. By Sample
    - 15.7.3.2.3. By End User
- 15.7.4. Malaysia Market
  - 15.7.4.1. Introduction
  - 15.7.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.7.4.2.1. By Test Type
    - 15.7.4.2.2. By Sample
    - 15.7.4.2.3. By End User

16. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Test Type
- 16.3.3. By Sample
- 16.3.4. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Test Type
- 16.4.3. By Sample
- 16.4.4. By End User
16.5. Market Trends
16.6. Market Drivers & Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
- 16.7.1. Australia Market
  - 16.7.1.1. Introduction
  - 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.1.2.1. By Test Type
    - 16.7.1.2.2. By Sample
    - 16.7.1.2.3. By End User
- 16.7.2. New Zealand Market
  - 16.7.2.1. Introduction
  - 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.2.2.1. By Test Type
    - 16.7.2.2.2. By Sample
    - 16.7.2.2.3. By End User

17. Middle East & Africa Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Turkiye
  - 17.3.1.3. South Africa
  - 17.3.1.4. Northern Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Test Type
- 17.3.3. By Sample
- 17.3.4. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Test Type
- 17.4.3. By Sample
- 17.4.4. By End User
17.5. Market Trends
17.6. Market Drivers & Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
- 17.7.1. GCC Countries Market
  - 17.7.1.1. Introduction
  - 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.7.1.2.1. By Test Type
    - 17.7.1.2.2. By Sample
    - 17.7.1.2.3. By End User
- 17.7.2. Turkiye Market
  - 17.7.2.1. Introduction
  - 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.7.2.2.1. By Test Type
    - 17.7.2.2.2. By Sample
    - 17.7.2.2.3. By End User
- 17.7.3. South Africa Market
  - 17.7.3.1. Introduction
  - 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.7.3.2.1. By Test Type
    - 17.7.3.2.2. By Sample
    - 17.7.3.2.3. By End User
- 17.7.4. Northern Africa Market
  - 17.7.4.1. Introduction
  - 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.7.4.2.1. By Test Type
    - 17.7.4.2.2. By Sample
    - 17.7.4.2.3. By End User

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies (Maternity Care Products)
18.2. Market Share Analysis of Top Players
18.3. Market Concentration

19. Competition Analysis

19.1. Competition Dashboard
19.2. Branding and Promotional Strategies, By key Players
19.3. Key Development Analysis
19.4. Competition Deep Dive
- 19.4.1. Abbott Laboratories
  - 19.4.1.1. Overview
  - 19.4.1.2. Product Portfolio
  - 19.4.1.3. Key Financials
  - 19.4.1.4. SWOT Analysis
  - 19.4.1.5. Key Developments
  - 19.4.1.6. Sales Footprint
  - 19.4.1.7. Strategy Overview
    - 19.4.1.7.1. Marketing Strategy
    - 19.4.1.7.2. Product Strategy
    - 19.4.1.7.3. Channel Strategy
- 19.4.2. Bio-Rad Laboratories Inc
  - 19.4.2.1. Overview
  - 19.4.2.2. Product Portfolio
  - 19.4.2.3. Key Financials
  - 19.4.2.4. SWOT Analysis
  - 19.4.2.5. Key Developments
  - 19.4.2.6. Sales Footprint
  - 19.4.2.7. Strategy Overview
    - 19.4.2.7.1. Marketing Strategy
    - 19.4.2.7.2. Product Strategy
    - 19.4.2.7.3. Channel Strategy
- 19.4.3. Affymetrix Inc.
  - 19.4.3.1. Overview
  - 19.4.3.2. Product Portfolio
  - 19.4.3.3. Key Financials
  - 19.4.3.4. SWOT Analysis
  - 19.4.3.5. Key Developments
  - 19.4.3.6. Sales Footprint
  - 19.4.3.7. Strategy Overview
    - 19.4.3.7.1. Marketing Strategy
    - 19.4.3.7.2. Product Strategy
    - 19.4.3.7.3. Channel Strategy
- 19.4.4. Beckman Coulter Inc.
  - 19.4.4.1. Overview
  - 19.4.4.2. Product Portfolio
  - 19.4.4.3. Key Financials
  - 19.4.4.4. SWOT Analysis
  - 19.4.4.5. Key Developments
  - 19.4.4.6. Sales Footprint
  - 19.4.4.7. Strategy Overview
    - 19.4.4.7.1. Marketing Strategy
    - 19.4.4.7.2. Product Strategy
    - 19.4.4.7.3. Channel Strategy
- 19.4.5. Biotest
  - 19.4.5.1. Overview
  - 19.4.5.2. Product Portfolio
  - 19.4.5.3. Key Financials
  - 19.4.5.4. SWOT Analysis
  - 19.4.5.5. Key Developments
  - 19.4.5.6. Sales Footprint
  - 19.4.5.7. Strategy Overview
    - 19.4.5.7.1. Marketing Strategy
    - 19.4.5.7.2. Product Strategy
    - 19.4.5.7.3. Channel Strategy
- 19.4.6. Cepheid Inc.
  - 19.4.6.1. Overview
  - 19.4.6.2. Product Portfolio
  - 19.4.6.3. Key Financials
  - 19.4.6.4. SWOT Analysis
  - 19.4.6.5. Key Developments
  - 19.4.6.6. Sales Footprint
  - 19.4.6.7. Strategy Overview
    - 19.4.6.7.1. Marketing Strategy
    - 19.4.6.7.2. Product Strategy
    - 19.4.6.7.3. Channel Strategy
- 19.4.7. GenBio
  - 19.4.7.1. Overview
  - 19.4.7.2. Product Portfolio
  - 19.4.7.3. Key Financials
  - 19.4.7.4. SWOT Analysis
  - 19.4.7.5. Key Developments
  - 19.4.7.6. Sales Footprint
  - 19.4.7.7. Strategy Overview
    - 19.4.7.7.1. Marketing Strategy
    - 19.4.7.7.2. Product Strategy
    - 19.4.7.7.3. Channel Strategy
- 19.4.8. Danaher Corporation
  - 19.4.8.1. Overview
  - 19.4.8.2. Product Portfolio
  - 19.4.8.3. Key Financials
  - 19.4.8.4. SWOT Analysis
  - 19.4.8.5. Key Developments
  - 19.4.8.6. Sales Footprint
  - 19.4.8.7. Strategy Overview
    - 19.4.8.7.1. Marketing Strategy
    - 19.4.8.7.2. Product Strategy
    - 19.4.8.7.3. Channel Strategy
- 19.4.9. Thermo Fisher Scientific
  - 19.4.9.1. Overview
  - 19.4.9.2. Product Portfolio
  - 19.4.9.3. Key Financials
  - 19.4.9.4. SWOT Analysis
  - 19.4.9.5. Key Developments
  - 19.4.9.6. Sales Footprint
  - 19.4.9.7. Strategy Overview
    - 19.4.9.7.1. Marketing Strategy
    - 19.4.9.7.2. Product Strategy
    - 19.4.9.7.3. Channel Strategy
- 19.4.10. Biomerica Inc.
  - 19.4.10.1. Overview
  - 19.4.10.2. Product Portfolio
  - 19.4.10.3. Key Financials
  - 19.4.10.4. SWOT Analysis
  - 19.4.10.5. Key Developments
  - 19.4.10.6. Sales Footprint
  - 19.4.10.7. Strategy Overview
    - 19.4.10.7.1. Marketing Strategy
    - 19.4.10.7.2. Product Strategy
    - 19.4.10.7.3. Channel Strategy
- 19.4.11. Biomerix
  - 19.4.11.1. Overview
  - 19.4.11.2. Product Portfolio
  - 19.4.11.3. Key Financials
  - 19.4.11.4. SWOT Analysis
  - 19.4.11.5. Key Developments
  - 19.4.11.6. Sales Footprint
  - 19.4.11.7. Strategy Overview
    - 19.4.11.7.1. Marketing Strategy
    - 19.4.11.7.2. Product Strategy
    - 19.4.11.7.3. Channel Strategy